Armando Tartaro1,2, Roberto Renzetti3, Michele De Cristofaro Aulisa4, Federica Morrone5, Andrea De Nicola6,7, Ekaterina Bliakharskaia7, and Paul E Summers7
1Department of Clinical, Oral and Biotechnology Sciences, University "G. d'Annunzio" Chieti-Pescara, Chieti-Pescara, Italy, 2Magnetic Resonance Service, Ospedale di Popoli, AUSL, Pescara, Italy, 3UOC of Urology, Ospedale di Pescara, AUSL, Pescara, Italy, 4Faculty of Medicine, University "G. d'Annunzio“, Chieti-Pescara, Chieti-Pescara, Italy, 5Radiology Department, Centro Morrone, Caserta, Italy, 6Ospedale di Chieti, Chieti, Italy, 7QMRI Tech, Pescara, Italy
Synopsis
Prostate dynamic contrast-enhanced (DCE) MRI
is often criticized for its weaknesses in terms of discriminating transition
zone lesions and tumors in general. Using high-temporal resolution DCE MRI in
patients who went on to prostatectomy, we evaluated time to peak (TTP), as well
as the enhancement rate factor, and initial enhancement slope of
a simple empirical mathematical model of early contrast uptake. Differences
between tumors and surrounding healthy tissues were seen for the mean values of
all three parameters. The AUCs were good (>0.8 in all
cases except for TTP between tumor and transition zone) but case numbers limited.
Introduction
The two compartment Toft’s model may not be appropriate for describing
contrast agent dynamics in healthy and diseased prostate tissues.1,2
The possibility that high temporal resolution dynamic contrast enhanced (DCE)
MRI together with an empirical mathematical model (EMM) may be informative
regarding the diagnosis of prostate cancer has been raised by Chatterjee et al.3
We have applied an EMM to examine the behavior
of contrast enhancement of apparently healthy and neoplastic prostate tissues in
high temporal resolution (< 2s/frame) DCE-MRI.Methods
In a cohort of 23 males with suspected prostate cancer, high
temporal resolution DCE MRI (temporal resolution 1.3s, repeated 3:15 m:ss) was
performed as part of a PI-RADS compliant multiparametric MRI examination of the
prostate.4 Other parameters of the 3D gradient echo DCE acquisition were:
FOV: 250x250x60mm, Acq. Res: 3.5x3.5x4mm, Acceleration: 3.5x SENSE, TR/TE/Flip
Angle 3.5ms/1.6ms/10°, on a 1.5T MR scanner (Achieva, Philips Medical Systems,
Best, The Netherlands) during injection of contrast agent (0.2ml/kg at 3ml/s;
Dotarem, Guerbet, Milan, Italy).
The first two timepoints of the DCE data were eliminated, and the
final frame prior to arrival of contrast in the iliac arteries (end baseline) identified,
and intensities normalized to the mean baseline signal. The EMM expression: C(t)=A(1−e−α(t-t0))
was then fit to the timeseries on a voxel-by-voxel basis to determine: -α (enhancement
rate factor), initial enhancement slope and arrival time (t0, not analyzed
further because the tightly packed values overlapped extensively between tissue
types). The time to peak (TTP) was also calculated
The DCE and b=0 DWI images were co-registered (3D Slicer) to the
T2-weighted images, and the transformations applied to the high b-value DWI
images, ADC maps and the maps derived from the DCE timeseries.
Regions of interest (ROIs) covering the index lesion on the all
T2 images (minimum 2) where it was visible were defined manually. On the same
slices, ROIs of healthy tissue encompassing the peripheral, transition and/or
central zone corresponding to the location of the tumor (possibly involving
more than one zone).
The ROIs were applied to
the DCE maps for value extraction. Descriptive statistics were calculated for
each tissue, and comparisons performed between tissues using one-way ANOVA for
the presence of differences in minimum, mean or maximum values between tissues.
Further, the ability to differentiate tumor from healthy tissue was assessed by
ROC analysis of the mean ROI values.Results
Two patients had lesions involving both PZ and CZ. These two ROIs
were replicated as distinct lesions for each zone, leading to 7 CZ, 14 PZ and 4
TZ lesions in our cohort.
Significant differences between tissues were seen for the mean
and maximum values of -α, iSlope, and TTP, while a significant difference
in the minimum values was only seen for iSlope. Specifically, lesions showed
lower values for -α and TTP than all other tissues, and a higher iSlope
than PZ and CZ. For all three parameters, the values seen in TZ were closest to
those seen in the lesions.
The AUCs for differentiation of tumor from
healthy tissue were: 0.8678, 0,8348 and 0.8504 for the mean values of -α,
iSlope and TTP respectively. Lower values of TTP and -α, and higher values
of iSlope were predictive of malignancy. AUC values for differentiating tumor
from the tissue in which the lesion was located are summarized in Table 2, but
we particularly small numbers of samples were involved for CZ (7 lesions) and TZ
(4 lesions).Discussion
In this small study, we found significant differences between
tumors and healthy tissues of the prostate as a whole for the mean EMM
parameters -α, iSlope and TTP. Moreover, relative to literature reports,
our measurements provided generally higher AUCs for the ROC curves of
differentiating tumor from healthy tissue both relative to the prostate in
general, and relative to the specific zone(s) in which the tumor was found. The
small numbers of cases for CZ and TZ however, warn against giving too much weight
to the relevance of this last observation.
Like Chatterjee et al.,3 this single center study
made use of a high-temporal resolution DCE MRI sequence that differs somewhat
from the sequences typically used in practice, and may not generalize to other
DCE acquisitions. The simpler EMM model used herein may, in part, explain the
difference in performance relative to their study.
A limitation of the present study may be the possibility of bias
introduced during the manual definition of the ROIs. Further, despite
registration, due to compromises on spatial resolution, the relatively small
ROIs involved may be subject to partial volume effects due to small errors in
operator-dependent delineation. Adoption of an automated segmentation tool that
relies on T2 and possible DWI data is under investigation and we hope will be
available for use in a larger cohort of subjects to reduce the risk of bias. Conclusion
A simple EMM of contrast enhancement provided relatively high
levels of performance in the discrimination of prostate tumors from healthy
tumor both when comparing to the whole prostate and the specific zones in which
the tumors were found.Acknowledgements
No acknowledgement found.References
1.
Noworolski SM, Vigneron DB, Chen AP, Kurhanewicz
J. Combined Dynamic Contrast-Enhanced MRI and MR Diffusion Imaging to
Distinguish Between Glandular and Stromal Prostatic Tissues. Magn Reson Imaging.
2008;26(8):1071-1080.
2.
Mustafi D, Gleber S-C, Ward J, et al. IV
Administered Gadodiamide Enters the Lumen of the Prostatic Glands: X-Ray
Fluorescence Microscopy Examination of a Mouse Model. Am J Roentgenol.
2015;205(3):W313-W319.
3.
Chatterjee A, He D,
Fan X, et al. Performance of Ultrafast DCE-MRI for Diagnosis of Prostate
Cancer. Acad Radiol. 2018;25(3):349-358.
4.
Turkbey B, Rosenkrantz
AB, Haider MA, et al. Prostate Imaging Reporting and Data System
Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version
2, Eur Urol. 2019;76(3):340–351.